FOLH1 and prostate carcinoma: Initial experience using 68Ga-PSMA PET/CT indicates that 68Ga-PSMA PET can visualize relapses and metastases of prostate cancer with high contrast through binding to the extracellular domain of PSMA and internalization (13).